Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

Source: Thailand Medical News  Feb 11, 2020  4 years, 2 weeks, 3 days, 15 hours, 27 minutes ago

New Coronavirus Test Kit Able To Provide Results In 30 Minutes

New Coronavirus Test Kit Able To Provide Results In 30 Minutes
Source: Thailand Medical News  Feb 11, 2020  4 years, 2 weeks, 3 days, 15 hours, 27 minutes ago
A California based molecular diagnostics company has announced that it has developed a new test kit for the new 2019-nCoV coronavirus that can provide results in less than 30 minutes.

Cepheid, a leading biotech and molecular diagnostics company  announced that in response to the rapid outbreak of a new coronavirus strain, the company has developed an automated molecular test for the qualitative detection of the 2019-nCoV coronavirus.
The test will be designed for use on any of its 23,000 GeneXpert® Systems placed worldwide and is expected to deliver point-of-care results in about less than 30 minutes.
Dr. David Persing, MD, Ph.D., Chief Medical and Technology Officer at Cepheid told Thailand Medical News, "The emergence of the 2019-nCoV coronavirus outbreak has put significant pressure on healthcare facilities. An accurate test with a rapid turnaround time delivered close to the patient will expedite diagnostic testing and help alleviate these pressures.”
He added further, “Over at Cepheid, we have managed to  leverage the design principles of our current Xpert® Xpress Flu/RSV cartridge technology, in which multiple regions of the viral genome are targeted to provide rapid detection of current and future pandemic coronavirus strains."
The company said that as a result of the virus rapidly spreading around the world plus intel collated from various sources that indicates that it is unlikely that the coronavirus would go away anytime soon, the company invested all its resources and capabilities into developing this new diagnostic test kit.
The biotech and molecular company has a history of responding quickly and working with global health organizations to help manage infectious disease outbreaks, such as Ebola virus and 2009 H1N1 influenza.
Once details are  finalized, Cepheid intends to access the FDA's Emergency Use Authorization pathway for regulatory approval and make the test available globally.
Cephied said that providing access to timely, highly accurate diagnostics that improve patient outcomes and public health worldwide is at the heart of Cepheid's mission.
Considering that time is a critical factor in managing the spread of the uot;font-size:14px">coronavirus as well as providing fast treatment to the infected as it is now known that for many, once infected with the coronavirus with initial signs such as fever and cough manifesting, it typically takes about three weeks for the patient’s condition to rapidly progress into a severe critical state.
The company plans to have the test kits commercially available with the next 7 to 14 days.
For latest developments and news about coronavirus research, the coronavirus epidemic or the Thailand Coronavirus scenario, keep on checking at:


Jun 10, 2023  9 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  1 year ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  4 years ago
Source: Supplements For COVID-19